What Claude Actually Did to the Riemann Hypothesis

Claude did not solve the Riemann Hypothesis. But what it actually did may be one of the clearest examples yet of how rapidly AI systems are changing the way difficult mathematics can be attacked. In Episode 53, Lester Nare and Krishna Choudhary go from first principles on arguably the most famous unsolved problem in mathematics. We begin with Euler and the Basel problem, build the Riemann zeta function from the ground up, show why it is intimately connected to prime numbers, explain analytic continuation and the famous 1 + 2 + 3 + 4 + … = -1/12 result, and finally arrive at the Riemann Hypothesis itself: the claim that every non-trivial zero of the zeta function lies on the critical line. Then we get into Claude. An unreleased Anthropic model was prompted to take a serious run at the problem. It orchestrated roughly 60 autonomous sub-agents, tested hundreds of mathematical approaches, executed Python code, searched academic literature, challenged its own proposed strategies, created adversarial referees to attack its work, and ultimately produced a new result pushing a related bound well beyond the previous state of the art. The strange part? The human prompting it was not a mathematician. One of his key instructions was essentially: “Believe in yourself.” We break down what Claude actually accomplished, what it absolutely did NOT accomplish, why moving a bound from roughly 42% toward two-thirds does not mean the Riemann Hypothesis is “two-thirds solved,” and what this tells us about the emerging capabilities of agentic AI systems in mathematics and scientific research. Then, in the second half, it’s transfer season. We introduce the Summer Transfer Window for Scientists and look at 42 researchers who have moved from American institutions to universities and research centers abroad over the past year—including major moves involving chemistry, battery research, gravitational-wave astrophysics, and neuroscience. We discuss what these transfers reveal about the increasingly competitive global market for scientific talent and the state of U.S. research funding.